We participated in Stage 1 of the Joint European Disruptive Initiative (JEDI) Grand Challenge to test 1 billion compounds as potential agents to treat COVID-19. We obtained predicted compounds for several SARS-CoV-2 targets.

Special thanks to Suhasini for the hard work on the reports, that we just submitted last night.

The JEDI will test compounds in Stage 2.